KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 111 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,672,197 | -18.9% | 1,247,908 | +8.4% | 0.00% | 0.0% |
| Q2 2023 | $2,060,721 | +3816050.0% | 1,151,241 | +8264.8% | 0.00% | – |
| Q1 2023 | $54 | -95.5% | 13,763 | -96.1% | 0.00% | -100.0% |
| Q4 2022 | $1,195 | -99.9% | 351,543 | +33.8% | 0.00% | 0.0% |
| Q3 2022 | $1,434,000 | -54.9% | 262,686 | -62.8% | 0.00% | -50.0% |
| Q2 2022 | $3,181,000 | -65.6% | 705,383 | -43.7% | 0.00% | -60.0% |
| Q1 2022 | $9,234,000 | -5.5% | 1,252,873 | -17.6% | 0.01% | 0.0% |
| Q4 2021 | $9,775,000 | +723.5% | 1,520,224 | +1221.8% | 0.01% | +400.0% |
| Q2 2021 | $1,187,000 | -84.7% | 115,013 | -84.5% | 0.00% | -83.3% |
| Q1 2021 | $7,782,000 | -82.2% | 739,714 | -73.8% | 0.01% | -80.6% |
| Q4 2020 | $43,709,000 | +1362.3% | 2,823,601 | +1279.6% | 0.03% | +675.0% |
| Q3 2020 | $2,989,000 | -63.9% | 204,673 | -53.2% | 0.00% | -63.6% |
| Q2 2020 | $8,290,000 | +563.7% | 437,690 | +573.4% | 0.01% | +266.7% |
| Q1 2020 | $1,249,000 | +382.2% | 65,000 | +381.6% | 0.00% | – |
| Q4 2019 | $259,000 | -97.9% | 13,496 | -99.0% | 0.00% | -100.0% |
| Q3 2019 | $12,368,000 | +260.6% | 1,285,699 | +124.5% | 0.02% | +233.3% |
| Q2 2019 | $3,430,000 | -78.4% | 572,655 | -78.9% | 0.01% | -75.0% |
| Q1 2019 | $15,883,000 | +278.7% | 2,719,714 | +507.6% | 0.02% | +242.9% |
| Q4 2018 | $4,194,000 | -71.4% | 447,607 | -48.0% | 0.01% | -61.1% |
| Q3 2018 | $14,653,000 | -17.0% | 860,441 | -17.2% | 0.02% | -21.7% |
| Q2 2018 | $17,661,000 | -10.1% | 1,039,469 | -29.0% | 0.02% | -14.8% |
| Q1 2018 | $19,639,000 | +368.3% | 1,463,368 | +235.0% | 0.03% | +350.0% |
| Q4 2017 | $4,194,000 | +3.0% | 436,836 | +17.8% | 0.01% | 0.0% |
| Q3 2017 | $4,073,000 | +105.4% | 370,916 | +69.2% | 0.01% | +50.0% |
| Q2 2017 | $1,983,000 | -40.3% | 219,157 | -15.2% | 0.00% | -33.3% |
| Q1 2017 | $3,319,000 | -50.4% | 258,495 | -63.7% | 0.01% | -57.1% |
| Q4 2016 | $6,685,000 | -21.2% | 711,156 | -18.4% | 0.01% | 0.0% |
| Q3 2016 | $8,483,000 | +77.0% | 871,861 | +22.1% | 0.01% | +27.3% |
| Q2 2016 | $4,792,000 | -58.9% | 714,104 | -45.3% | 0.01% | -62.1% |
| Q1 2016 | $11,653,000 | -32.1% | 1,306,393 | +0.9% | 0.03% | -19.4% |
| Q4 2015 | $17,150,000 | +58.8% | 1,294,345 | +26.2% | 0.04% | +71.4% |
| Q3 2015 | $10,801,000 | +8.9% | 1,025,731 | +181.4% | 0.02% | +10.5% |
| Q2 2015 | $9,917,000 | +237.1% | 364,452 | +279.2% | 0.02% | +280.0% |
| Q1 2015 | $2,942,000 | +57.2% | 96,114 | +92.2% | 0.01% | +25.0% |
| Q4 2014 | $1,872,000 | +26.1% | 50,000 | +56.7% | 0.00% | 0.0% |
| Q2 2014 | $1,485,000 | +201.8% | 31,900 | +48.7% | 0.00% | +100.0% |
| Q4 2013 | $492,000 | – | 21,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |